Ribocure Pharmaceuticals

Company Drug

RiboLife’s RBD1016 Earns EMA Orphan Designation with RiboGalSTAR Platform

Fineline Cube Oct 24, 2025

Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals AB announced today that...

Company

Suzhou Ribo Life Science Receives EU Approval for Phase II Trial of RBD5044

Fineline Cube Nov 16, 2024

Suzhou Ribo Life Science Co., Ltd. and its subsidiary Ribocure Pharmaceuticals AB have announced that...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod